Follow us
Nigeria Health Watch
Follow us:
Subscribe to our Newsletter
breadcrumb banner

CEPI

Search

Categories

Recent Posts

Post Image

As Efforts Intensify to Contain Bundibugyo Ebola, Women Remain Most Vulnerable to Its Economic Impact

Jul 06, 2026
Post Image

An Epidemic of Parastatals in Nigeria’s Health Sector

Jul 04, 2026
Post Image

From Innovation to Integration: What It Will Take to Make Every Pregnancy Safer in Nigeria

Jul 03, 2026
Post Image

Community Feedback Prompts PHC Upgrade in Gauraka, Niger State

Jul 03, 2026
Post Image

Why Zambia is Rethinking Tuberculosis Testing, and Why Validation Must Come First

Jul 02, 2026
Blog Image 4 Apr

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

By Nigeria Health Watch | April 4, 2024

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate Key takeaways • Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2 clinical trial of any Lassa vaccine.• Lassa fever is a deadly hemorrhagic fever common to West Africa. […]

Read More
Blog Image 13 Jul

CEPI: Accelerating Lassa Fever Vaccine Development in Nigeria

By Nigeria Health Watch | July 13, 2023

The law of inertia, referred to as Newton’s first law of motion, states that “an object will remain at rest or in uniform motion in a straight line unless compelled to change its state by the action of an external force”. This is similar to the Coalition for Epidemic Preparedness Innovation’s (CEPI) mission to accelerate […]

Read More
Blog Image 20 Jul

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa

By Nigeria Health Watch | July 20, 2021

July 20, 2021; Oslo, Norway and Seoul, Republic of Korea: The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding of up to $12.7m to the Expanding Access and Delivery of […]

Read More
Blog Image 15 Jun

EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development

By Nigeria Health Watch | June 15, 2021

Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access NEW YORK, THE HAGUE, AND OSLO – JUNE 15, 2021 – IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Coalition for Epidemic Preparedness Innovations (CEPI) to conduct […]

Read More
Blog Image 15 Apr

CEPI and the African Union join forces to boost African vaccine R&D and manufacturing

By Nigeria Health Watch | April 15, 2021

Oslo, Norway, and Addis Ababa, Ethiopia; April 13, 2021—The Coalition for Epidemic Preparedness Innovations (CEPI) and the African Union Commission have today announced the signing of an memorandum of understanding, which aims to strengthen ties between the organisations and the Africa CDC—a specialised institution of the African Union responsible for the prevention and control of […]

Read More